Revelation Biosciences, Inc. (NASDAQ:REVB) Financings

Revelation Biosciences, Inc.

Financings

RaiseDate
Public offering of common stock (or common stock equivalents) and warrants
Closed: US$4M raised · US$1.1 a share · Warrants at US$1.1 for 60 months · Roth Capital Partners
Dealers: Roth Capital Partners (lead)
Use of proceeds: Product candidate development incl. Phase 1b study, clinical drug supply, preclinical work, other products, working capital
May 29, 2025

Read by 6ix AI from the company's releases